Show Summary Details
Page of

Psychopharmacology During Pregnancy: Infant Considerations 

Psychopharmacology During Pregnancy: Infant Considerations
Psychopharmacology During Pregnancy: Infant Considerations

C. Neill Epperson

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 October 2021

Chapter 44 hopes to educate child mental healthcare providers regarding the potential behavioral and health sequelae of in-utero exposure to psychotropic medications, as well as to the sequelae of exposure to maternal mental distress; and to enable clinicians treating mentally ill women of childbearing age to develop a more informed and rational approach to prescribing psychotropic medications to pregnant women.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.